Turn Therapeutics (TTRX) Cash from Operations (2024 - 2026)
Turn Therapeutics (TTRX) posted quarterly Cash from Operations of 1600000.0 for Q1 2026, down 436.81% year-over-year from 475047.71 in Q1 2025, and down 32.23% quarter-over-quarter from 1210000.0 in Q4 2025.
Turn Therapeutics (TTRX) Cash from Operations (2024 - 2026) Analysis & Trends
Turn Therapeutics' Cash from Operations history runs 3 years deep, the most recent figure standing at 1600000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 436.81% year-over-year to 1600000.0; the TTM figure through Mar 2026 stood at 3538603.0 (changed N/A YoY), while the FY2025 annual figure was 2600000.0, down 90.99% from the prior year.
- Cash from Operations for Q1 2026 stood at 1600000.0, down from 1210000.0 in the prior quarter.
- The five-year high for Cash from Operations was 298058.0 in Q1 2025, with the low at 1600000.0 in Q1 2026.
- The 3-year median for Cash from Operations is 820272.5 (2024), against an average of 884650.75.
- The sharpest annual moves came in 2025 and 2026: Cash from Operations sank 181.04% in 2025, then slumped 436.81% in 2026.
- Turn Therapeutics' Cash from Operations stood at 430545.0 in 2024, then sank by 181.04% to 1210000.0 in 2025, then tumbled by 32.23% to 1600000.0 in 2026.
- Business Quant data shows TTRX's Cash from Operations at 1600000.0 in Q1 2026, 1210000.0 in Q4 2025, and 298058.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Turn Therapeutics | 285.07 Mn | 285.07 Mn | - | -967,193.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -967,193.00 |
| Jun 30, 2026 | -967,193.00 |
| Mar 31, 2026 | -1.60 Mn |
| Mar 31, 2026 | -1.60 Mn |
| Dec 31, 2025 | -1.21 Mn |
| Dec 31, 2025 | -1.21 Mn |
| Mar 31, 2025 | -298,058.00 |
| Mar 31, 2025 | -298,058.00 |
| Dec 31, 2024 | -430,545.00 |
| Dec 31, 2024 | -430,545.00 |